Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ruof

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Zeitschrift Fur Rheumatologie|March 15, 2006
[Productivity costs of rheumatoid arthritis in Germany. Cost composition and prediction of main cost components]S Merkesdal, J L Huelsemann, T Mittendorf, et al.
Health Policy (Amsterdam, Netherlands)|July 6, 2020
Review of Relative effectiveness assessments (REAs) of pharmaceuticals at the European network for health technology assessment (EUnetHTA): A first step towards a consolidated European perspective on comparative effectiveness & safety?F Chassagnol, G Marcelli, J Wagle, et al.
The Journal of Rheumatology|April 12, 2001
Development of a matrix of cost domains in economic evaluation of rheumatoid arthritisS Merkesdal, J Ruof, J L Huelsemann, et al.
The Journal of Rheumatology|April 12, 2001
Cost assessment instrument in rheumatology: evaluation of applied instrument characteristicsJ Ruof, S Merkesdal, J L Huelsemann, et al.
Zeitschrift Fur Rheumatologie|November 2, 2004
[Conceptual and methodological basics of cost assessments in rheumatology]J Ruof, J L Hülsemann, T Mittendorf, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 21, 2004
Implementing standardized cost categories within economic evaluations in musculoskeletal diseasesT Mittendorf, S Merkesdal, J L Huelsemann, et al.
Annals of the Rheumatic Diseases|May 22, 2003
Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer's data sourcesJ Ruof, J L Hülsemann, T Mittendorf, et al.
Annals of the Rheumatic Diseases|April 1, 2005
Direct costs related to rheumatoid arthritis: the patient perspectiveJ L Hülsemann, T Mittendorf, S Merkesdal, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Zeitschrift Fur Rheumatologie|March 15, 2006
[Productivity costs of rheumatoid arthritis in Germany. Cost composition and prediction of main cost components]S Merkesdal, J L Huelsemann, T Mittendorf, et al.
Health Policy (Amsterdam, Netherlands)|July 6, 2020
Review of Relative effectiveness assessments (REAs) of pharmaceuticals at the European network for health technology assessment (EUnetHTA): A first step towards a consolidated European perspective on comparative effectiveness & safety?F Chassagnol, G Marcelli, J Wagle, et al.
The Journal of Rheumatology|April 12, 2001
Development of a matrix of cost domains in economic evaluation of rheumatoid arthritisS Merkesdal, J Ruof, J L Huelsemann, et al.
The Journal of Rheumatology|April 12, 2001
Cost assessment instrument in rheumatology: evaluation of applied instrument characteristicsJ Ruof, S Merkesdal, J L Huelsemann, et al.
Zeitschrift Fur Rheumatologie|November 2, 2004
[Conceptual and methodological basics of cost assessments in rheumatology]J Ruof, J L Hülsemann, T Mittendorf, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 21, 2004
Implementing standardized cost categories within economic evaluations in musculoskeletal diseasesT Mittendorf, S Merkesdal, J L Huelsemann, et al.
Annals of the Rheumatic Diseases|May 22, 2003
Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer's data sourcesJ Ruof, J L Hülsemann, T Mittendorf, et al.
Annals of the Rheumatic Diseases|April 1, 2005
Direct costs related to rheumatoid arthritis: the patient perspectiveJ L Hülsemann, T Mittendorf, S Merkesdal, et al.
Pageof 3